stocktools
Dilution profile // every instrument, one screen, from SEC filings

Connect Biopharma Holdings Ltd (CNTB)

CIK 1835268 · all EDGAR filings →

Overall dilution risk
MEDIUMworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
MEDIUM$14.5M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW+14% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
MEDIUM~10.8 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-12-312026-04-30

Latest: 63.0M shares as of Apr 30, 2026 (10-Q).

Cash runway

~11 months of cash left

burning $12.8M / quarter

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed May 12, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Registered offering capacity on live registrations: $14.5Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-3May 15, 2026$14.5M registeredfiling →
F-3Jun 10, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 1 executed · 1 registered.

EFFECTIVEJun 1, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 15, 2026F-3 registration — capacity to sell shares, not a sale yetF-3 →
EXECUTEDMar 30, 2026Unregistered share sale disclosed (8-K item 3.02)8-K →
EFFECTIVESep 12, 2025SEC declared a registration effective — selling can beginEFFECT →
EFFECTIVEJun 26, 2025SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJun 10, 2025F-3 registration — capacity to sell shares, not a sale yetF-3 →
EFFECTIVEJul 6, 2022SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJun 17, 2022F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
REGISTEREDMay 23, 2022F-3/A registration — capacity to sell shares, not a sale yetF-3/A →
REGISTEREDApr 15, 2022F-3 registration — capacity to sell shares, not a sale yetF-3 →
EXECUTEDMar 19, 2021Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDMar 18, 2021F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full CNTB workspace